drugset / Trial / NCT01231854

Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.

NCT01231854

Phase 4 Terminated 15 enrolled Technical University Dresden
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the comparative efficacy, safety and efficiency of ciclosporin microemulsion and alitretinoin in adults with severe atopic hand dermatitis.

Timeline

Start
2010-11
Primary completion
2012-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide 200 mg Oral
Comparator Cyclosporine Peptide 300 mg Oral
Comparator alitretinoin Other / unclassified 30 mg Oral

Indications